Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medline Inc. Class A Common Stock (MDLN) vs Okta, Inc. (OKTA) Price & Performance

Medline Inc. Class A Common StockTrade
Okta, Inc.Trade

Price performance (Past 24H)

Key statistics

Medline Inc. Class A Common Stock vs Okta, Inc. — how do they compare? Medline Inc. Class A Common Stock trades at $35.74 (market cap $31.36B), while Okta, Inc. trades at $222.45 (market cap $38.50B). The key difference: Okta, Inc. is the larger of the two by market cap, and Okta, Inc. is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Okta, Inc. for 44 Days on average.

MDLNOKTA
Market Cap
$31.36B$38.50B
Volume
10,191,2512,479,621
Sector
HealthTechnology
52-Week High
$49.99$220.21
52-Week Low
$31.64$62.93
Typical Hold Time
0 Days44 Days
Enterprise Value
$41.32B$36.25B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medline Inc. Class A Common Stock

No Aura AI signal available yet.

Okta, Inc.

OKTA trades at $218.00, down 0.31% on the day, with a bullish technical signal supported by moving averages. The company shows strong revenue growth, reaching $2.61 billion in 2025 with a net income turnaround to $28 million. Recent earnings beats and positive analyst sentiment (73.58% buy ratings) highlight momentum, though high valuation ratios like a P/E of 131.33 pose concerns. Key developments include AI security initiatives unveiled at Oktane 2026, driving media attention.

Outlook: OKTA's focus on AI agent security and identity management positions it for growth in cybersecurity, but elevated valuations and insider selling require caution. Risks include competitive pressures and execution challenges. The consensus price target of $201.30 suggests modest downside, yet innovation catalysts offer long-term potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDLN
100% Buy0% Sell
Avg holding period · 0 Days
OKTA
70% Buy30% Sell
Avg holding period · 44 Days

About Medline Inc. Class A Common Stock

Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.

Read more on MDLN →

About Okta, Inc.

Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.

Read more on OKTA →